Chemoprophylaxis for HIV Prevention in Men Expansion Study [III] |
South Africa; Thailand; Brazil; Ecuador; Peru |
HIV/AIDS |
|
|
Chemoprophylaxis for HIV Prevention in Men Expansion Study [I] |
South Africa; Thailand; Brazil; Ecuador; Peru |
HIV/AIDS |
|
|
Comparison of Pharmacologic Markers of Exposure to HIV Pre-Exposure Prophylaxis |
United States |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Chemoprophylaxis for HIV Prevention: Analysis of Bone and Metabolic Effects |
United States |
HIV/AIDS |
|
|
Statistical methods for clinical trials of novel PrEP agents |
United States |
HIV/AIDS, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development |
|
|
Failure Time Methods for Family Disease Studies |
United States; Australia |
Cardiovascular Disease |
|
|
Chemoprophylaxis for HIV Prevention in Men Expansion Study [II] |
South Africa; Thailand; Brazil; Ecuador; Peru |
HIV/AIDS |
|
|